AI assistant
Clene Inc. — Director's Dealing 2021
May 25, 2021
34487_dirs_2021-05-25_27c77871-c68a-4c64-9f56-e8c99416b7cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2021-05-18
Reporting Person: MATLIN DAVID J (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-18 | Stock Options (Right to buy) | $9.10 | A | 3170.00 | Acquired | 2031-05-18 | Common Stock (3170.00) | Direct |
| 2021-05-18 | Stock Options (Right to buy) | $9.10 | A | 30000.00 | Acquired | 2031-05-18 | Common Stock (30000.00) | Direct |
Footnotes
F1: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021. The corrected exercise price is $9.10 and the corrected number of options granted is 3,170.
F2: This option was granted on May18, 2021 as an option for 3,170 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest immediately upon grant.
F3: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021 to reflect a correction in the exercise price related to the grant of an option for 30,000 shares of common stock of Clene Inc.
F4: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested.